COMMUNIQUÉS West-GlobeNewswire
-
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors
23/03/2026 -
Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine
23/03/2026 -
Standard Dental Labs Inc. Engages Strategic Advisor to Support Lab Acquisition Strategy
23/03/2026 -
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
23/03/2026 -
CareMore Health Announces Appointment of Dr. Anh Pham as Chief Medical Officer
23/03/2026 -
AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass
23/03/2026 -
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
23/03/2026 -
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
23/03/2026 -
Cortexa Advances Commercialisation of MDMA Supply in Australia
23/03/2026 -
SafeSpace Global Secures Shareholder Approval to Increase Authorized Shares of Common Stock
23/03/2026 -
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
23/03/2026 -
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
23/03/2026 -
Checkerspot Announces Breakthrough, using Microalgae to Produce Palmitoleic Acid Oil at Scale, Opening a New Pathway to Omega-7s
23/03/2026 -
Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
23/03/2026 -
Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support Innovations
23/03/2026 -
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
23/03/2026 -
NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit
23/03/2026 -
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
23/03/2026 -
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
23/03/2026
Pages